3,4,5,6-Tetrakis(3,6-diphenyl-9H-carbazol-9-yl)phthalonitrile, 98%, 250mg

tert-Butyl (R)-(1-(3-(4-Ethoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)carbamate, 95%, 1g

3-(N-Boc-N-Propylamino)phenylboronic acid, 98%, 100mg

Methyl 2-(2-bromo-3,6-difluorophenyl)acetate, 97%, 1g

Benzoylurea>98.0%(HPLC)(N)500g

GC capillary column ROTI®Cap-1, 60 m, 0.25 mm, 0.10 µm, 1 Piece(s)

1-Phenyl-3-trifluoromethyl-1H-pyrazole-5-carboxamide, 95.0%, 1g

Methyl 2-(aminomethyl)nicotinate dihydrochloride, 5g

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-D-methionine, 97%, 250mg

4-tert-Butylbenzohydrazide>98.0%(HPLC)5g

(S)-4-(tert-Butoxy)-2-isopropyl-4-oxobutanoic acid, 95.0%, 1g

(3-Amino-4-bromophenyl)methanol, 97%, 25g

4-Chloro-2-ethylquinazoline, 95+%, 250mg